To evaluate efficacy and safety of amphotericin B in two different doses in the treatment of post kala-azar dermal leishmaniasis (PKDL)

Vidya Nand Rabi Das, Niyamat Ali Siddiqui, Biplab Pal, Chandra Shekhar Lal, Neena Verma, Ashish Kumar, Rakesh Bihari Verma, Dhirendra Kumar, Pradeep Das, Krishna Pandey

Open source

DOI: 10.1371/journal.pone.0174497
Published: 2017-03-29
Container: PLOS ONE
Publisher: Public Library of Science (PLoS)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0174497,
  title = {To evaluate efficacy and safety of amphotericin B in two different doses in the treatment of post kala-azar dermal leishmaniasis (PKDL)},
  author = {Vidya Nand Rabi Das and Niyamat Ali Siddiqui and Biplab Pal and Chandra Shekhar Lal and Neena Verma and Ashish Kumar and Rakesh Bihari Verma and Dhirendra Kumar and Pradeep Das and Krishna Pandey},
  year = {2017},
  journal = {PLOS ONE},
  doi = {10.1371/journal.pone.0174497},
  url = {https://doi.org/10.1371/journal.pone.0174497}
}

RIS

TY  - JOUR
TI  - To evaluate efficacy and safety of amphotericin B in two different doses in the treatment of post kala-azar dermal leishmaniasis (PKDL)
AU  - Vidya Nand Rabi Das
AU  - Niyamat Ali Siddiqui
AU  - Biplab Pal
AU  - Chandra Shekhar Lal
AU  - Neena Verma
AU  - Ashish Kumar
AU  - Rakesh Bihari Verma
AU  - Dhirendra Kumar
AU  - Pradeep Das
AU  - Krishna Pandey
PY  - 2017
JO  - PLOS ONE
DO  - 10.1371/journal.pone.0174497
UR  - https://doi.org/10.1371/journal.pone.0174497
ER  -

APA

Das, V. N. R., Siddiqui, N. A., Pal, B., Lal, C. S., Verma, N., Kumar, A., Verma, R. B., Kumar, D., Das, P., & Pandey, K. (2017). To evaluate efficacy and safety of amphotericin B in two different doses in the treatment of post kala-azar dermal leishmaniasis (PKDL). PLOS ONE. https://doi.org/10.1371/journal.pone.0174497

Source records

crossref · retrieved 2026-09-25T04:50:51.761Z